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THE THREE-DIMENSIONAL (3-D) ARCHITECTURE of parenchymal organs such as mammary gland, kidney, lung, and pancreas is established during embryonic development through coordinated and sequential morphogenetic events. These include the outgrowths of solid cellular cords from a primitive epithelial bud, cell polarization, and lumen formation leading to the generation of tubular structures, and finally, tube elongation and branching (1, 28) . Failure of any of these fundamental processes may result in aberrant organogenesis.
Over the last 2 decades, it has become clear that the processes involved in the formation and branching of epithelial tubules are orchestrated by growth factors. The most characterized tubulogenic cytokines are hepatocyte growth factor (HGF) (3, 31) , glial cell-derived neurotropic factor (15, 54) , and several members of the fibroblast growth factor family (4, 20) . In addition to regulation by growth factors, epithelial cell interactions with extracellular matrix (ECM) components are believed to play a pivotal role in epithelial tubulogenesis (44) .
Identifying the constellation of extracellular cues that control branching tubulogenesis is made difficult by the complexity of cell interactions occurring in vivo. To overcome this drawback, several groups including our own have designed 3-D culture systems that faithfully recapitulate key events of branching tubulogenesis, thereby facilitating its molecular analysis (57) . In particular, kidney-derived MDCK and mCCD-N21 cells, and mammary gland-derived J3B1A cells represent well-characterized models for studying branching morphogenesis. When grown in collagen gels, J3B1A and MDCK cells form spherical cysts with a central lumen lined by a cell monolayer. Upon exposure to appropriate inductive stimuli, both cell lines generate tubular structures (29, 31) .
The aim of this study was to assess whether synthesis of hyaluronic acid (HA), a key component of the ECM, is required for the formation of branching tubules. HA, also known as hyaluronan, is a high molecular weight glycosaminoglycan composed of thousands of disaccharide units of glucuronic acid and N-acetyl glucosamine. It is particularly abundant in the pericellular matrix that surrounds migrating cells during embryonic development and tissue remodeling (2, 51) . HA is synthesized by one of three different but related hyaluronan synthases, named Has1, Has2, and Has3. Each hyaluronan synthase exhibits different catalytic properties and expression patterns during embryonic development, suggesting that they play distinct roles (49) . The Has2 isoform is the most extensively regulated in response to external stimuli (24) .
Previous studies have supported a role for HA in the development of epithelial organs such as the prostate gland (19) and kidney (38, 43, 48) . However, it has not been established whether endogenously produced HA is actually necessary for tubule formation. To address this issue, we took advantage of three different in vitro assays of epithelial morphogenesis developed in our laboratory: 1) tube formation by mammary gland-derived J3B1A cells in response to low concentrations of transforming growth factor-␤1 (TGF-␤1) (29) ; 2) tube formation by kidney-derived MDCK cells in response to addition of HGF (31) ; and 3) spontaneous tube formation by collecting duct mCCD-N21 cells (30) . Using these experimental models, we show that Has2 expression and HA produced at the tips of epithelial cells play a critical role in driving tubulogenesis and branching in vitro.
MATERIALS AND METHODS
Reagents. Human platelet TGF-␤1 was purchased from R&D Systems (Minneapolis, MN), HGF was a gift from the late R. Schwall (Genentech, San Francisco, CA), and 4-methylumbelliferone (4-MU) was purchased from Sigma (St Louis, MO).
Cells. J3B1A cells (34) , a clonal derivative of the murine EpH4 mammary epithelial cell line (33) , were grown in DMEM with Glutamax (Life Sciences, Bern, Switzerland) supplemented with 10% decomplemented donor calf serum (DCS; Life Sciences). Canine renal MDCK II Tet-Off cells were obtained from Clontech (Palo Alto, CA). Cells were grown in DMEM with Glutamax supplemented with 5% FCS (Life Sciences). mCCD-N21 mouse kidney cells (30) were grown in a 1:1 mixture of DMEM and F12 medium with Glutamax (DMEM/F12; Life Sciences) supplemented with 2% FCS, 5 g/ml insulin (Sigma), 5 g/ml holo-transferrin (Sigma), 10 ng/ml epidermal growth factor (EGF; Pepro Tech, London, UK), 50 nM dexa-methasone (Sigma), 60 nM sodium selenite (Sigma), and 1 nM 3,3=,5-triiodo-L-thyronine (Sigma).
MDCK cells were transfected with pCDNA6.2 BLOCK-iT miR RNAi plasmid (Life Sciences) encoding enhanced green fluorescent protein (eGFP) and an engineered miR RNA sequence (derived from the murine miR-155 miRNA structure) targeting the HAS2 gene. Sequences for miRNA were 5=-TTGAACAAGACTGTTGCTCTT-3= for MDCK clone mi-1 and 5=-AAACTCCTTGCTGCATGAATT-3= for MDCK clone mi-2. Stably transfected clones were selected with 7 g/ml blasticidin and were sorted using fluorescence-activated cell sorting on the basis of eGFP expression to ensure high expression levels of the miRNA. J3B1A cells were transduced with pLVTHM lentiviral vector encoding RFP and shRNA targeting Has2. J3B1A and mCCD-N21 cells were transduced with pTRIPZ lentiviral vector (Thermo Scientific Open Biosystems) encoding sh-mir RNA (microRNA adapted shRNA) targeting Has2 (for mCCD-N21 cells), CD44, or RHAMM. Has2 targeted sequences were 5=-GGAAGAC-CATTGTTGTTAA-3= for clone J3B1A sh1, 5=-ATTGTGAGAG-GTTTCTATG-3= for the experiment involving heterogeneous populations of transduced and untransduced cells, and 5=-AGAAGAC-CATTGTTGTTAATTT-3= for mCCD-N21 sh H2. The CD44 sequence was used to target the common part of CD44 variants, 5=-CGATGCCAGAGAGACATTTAAA-3= (8) and RHAMM (receptor for HA-mediated motility), 5=-CCGTCTTTAAAGAAGAGCT-AAA-3=. All oligonucleotides were from Life Sciences.
Lentiviral transduction. Lentiviruses were freshly prepared by transfection of HEK cells with a mixture of three plasmids: pMD2G and psPAX2 for production of lentiviral particles, and the plasmid of interest. Conditioned medium of HEK cells was harvested for 2 days and centrifuged at high speed to purify lentiviral particles. The lentiviral particles were resuspended in PBS, and 100 l of the preparation was added to cells plated at 2 ϫ 10 6 cells per 10-cm dish the day before transduction. After performing a second incubation with 100 l of the preparation, transduced cells were selected by addition of 1 or 3 g/ml puromycin for mCCD-N21 or J3B1A cells, respectively.
Microarray analysis. J3B1A cells were grown in collagen gels for 6 days until they formed cystic structures and were subsequently treated or not treated with 50 pg/ml TGF-␤1 for 24 h. Cells were released from collagen gels by digestion with collagenase (4 mg/ml for 20 min at 37°C) and total RNA was extracted with a Charge Switch total RNA kit (Life Technologies). RNA quality was assessed by capillary electrophoresis on an Agilent 2100 Bioanalyzer. One hundred nanograms of RNA was amplified and labeled using the double amplification procedure according to the protocol developed by Affymetrix (GeneChip Eukaryotic Small Sample Target Labeling Assay Version II; Affymetrix, Santa Clara, CA). Hybridization on GeneChip Mouse Genome 430A 2.0 arrays (Affymetrix) was carried out according to the manufacturer's instructions. The data were normalized using a robust multiarray analysis technique (6) . To assess the difference in gene expression values between control and TGF-␤1-treated cells, we performed a one-way ANOVA with contrast in the Partek Genomics Suite (http://www.partek.com). P values were corrected for multiple testing by use of false-discovery rate method chips. Data are available in the ArrayExpress database (www.ebi. ac.uk/arrayexpress) under accession number E-MTAB-2097.
Morphogenesis assays. J3B1A cells were mixed with a type I collagen solution prepared as previously described (32) to obtain a concentration of 1 ϫ 10 4 cells/ml, and 0.5-ml aliquots of the cell suspension were dispensed into 16-mm wells. After a 10-min incubation at 37°C to allow collagen gelation, 0.5 ml of defined medium consisting of DMEM/F12, ITSϩ Premix (6.25 g/ml insulin, 6.25 g/ml transferrin, 6.25 ng/ml selenious acid, 1.25 mg/ml bovine serum albumin, and 5.35 g/ml linoleic acid; BD Biosciences, Bedford, MA), 2 ng/ml EGF (Pepro Tech), and 5 nM all-trans-retinoic acid (RA; Sigma) was added to the gels. Collagen gel cultures were then incubated in defined medium for 6 days to allow the formation of cystic structures (34) . Thereafter, fresh defined medium was added with or without the indicated treatments.
MDCK cells were mixed with collagen as described for J3B1A cells. Cells were treated directly after collagen gelation with the indicated agent in their normal medium.
mCCD-N21 cells were suspended in DMEM/F12 supplemented with 1% FCS, 5 g/ml insulin, 5 g/ml holo-transferrin, 60 nM sodium selenite, 10 ng/ml EGF, 10 ng/ml HGF, and 10 nM RA (this medium is hereafter referred to as the assay medium). The cells were then mixed with an ECM solution composed of 80% type I collagen and 20% growth-factor-reduced Matrigel (BD Biosciences, Franklin Lakes, NJ) at a final concentration of 2 ϫ 10 4 cells/ml. A 20-l drop of the cell suspension was placed in a 16-mm well and, after gel solidification, overlaid with 500 l of assay medium. The cultures were treated with the specified agent at the indicated time.
Chimeric cell aggregates were obtained by seeding a mixture of MDCK cells expressing HAS2 miRNA (and eGFP) and MDCK Tet-Off cells overexpressing HAS2 in nonadhesive agarose-coated 12-well plates at a density of 5 ϫ 10 4 and 1 ϫ 10 5 cells, respectively. Cells were grown for 2-3 days in suspension until they formed floating mixed clusters. The clusters were then harvested by centrifugation and resuspended in 3-D collagen gels, within which they rearranged to form spherical cystic structures.
Micrographs were taken under brightfield illumination using the ϫ10 or ϫ20 objectives of a Nikon Diaphot TMD inverted photomicroscope (Nikon, Egg, Switzerland).
Particle exclusion assay. J3B1A cells were seeded at low density (200 cells/16-mm well) and treated or not treated with TGF-␤1 (200 pg/ml) or HGF (7 ng/ml), respectively, for 48 h. Fixed erythrocytes were then added to the medium (2 ϫ 10 6 erythrocytes/well) and allowed to sediment for 15 min. HA-rich pericellular coats were visualized under brightfield illumination using the ϫ20 objective of a Nikon Diaphot TMD inverted microscope. Controls were performed by addition of Streptomyces hyaluronidase (2 U/ml, 1 h at 37°C) before adding the fixed erythrocytes.
Immunofluorescence. J3B1A, MDCK, and mCCD-N21 cells were grown for the appropriate time in collagen gels (J3B1A and MDCK) or collagen/Matrigel drops (mCCD-N21) to allow cyst or tubule formation. Gels were fixed either in 4% paraformaldehyde in PBS for 30 min (for all immunostaining except HA) or in 4% paraformaldehyde for 15 min and then in FEA solution (formaldehyde 4%, ethanol 70%, acetic acid 5%) for 5 min to preserve hyaluronic acid (27) . Gels were rinsed three times in PBS, cut into small pieces, permeabilized in 0.02% Triton X-100 for 5 min or with PSG buffer (PBS, 20 mM glycine, 0.1% saponin, 0.05% NaN3, pH 7.4) for 2 h at 4°C (for acetylated alpha tubulin), and then incubated overnight with different antibodies diluted in PBS: CD44 (IM7 for MDCK cells or KM201 for murine cells; Abcam, Cambridge, UK) 1/400; Na,K-ATPase (14); acetylated alpha tubulin (Sigma) 1/2,000; or with biotinylated HAbinding peptide (Calbiochem) 1/100. After rinsing in PBS, samples were incubated for 1 h at room temperature with the appropriate FITC-conjugated secondary antibody (Jackson Immunoresearch, Suffolk, UK) (1:200) or Phycoerythrin-conjugated Streptavidin (1:100; BD Pharmingen, Allschwil, Switzerland) (HA staining). If appropriate, structures were counterstained with Alexa 488-or rhodamineconjugated phalloidin (1:250; Molecular Probes, Basel, Switzerland). Gels were mounted on microscope slides provided with a shallow cavity using Prolong Gold antifade reagent (Molecular Probes) containing DAPI (4,6-diamidino-2-phenylindole) to counterstain nuclei. Fluorescence was detected using a Leica SP5-2 photon confocal laser scanning microscope (Leica, Heerbrugg, Switzerland). Negative controls were performed by omission of the primary antibody and, for HA detection, by treating the gels with Streptomyces hyaluronidase (Calbiochem; 2 U/ml, 1 h at 37°C) before HA staining.
Real-time PCR. RNA extraction, reverse transcription, and realtime PCR analysis were performed as previously described (21) . When mentioned, RNA was extracted from cells grown in 3-D gels.
Gels were treated with 4 mg/ml collagenase (Worthington, Lakewood, NJ) for 15 min at 37°C, then cells were harvested by centrifugation, and RNA was extracted using Nucleospin RNAII (Macherey-Nagel, Düren, Germany) following the manufacturer's instruction. Primers used for detection of the different genes were, for forward and reverse, respectively, as follows: murine Has2, 5=-GGGAACTCAGACGAC-GACCTT-3= and 5=-GATGTACGTGGCCGATTTGTC-3=; murine Has1, 5=-AGAATCCAGGAGGACCCACAG-3= and 5=-TCTG-AGGGCTTTGGCATGTC-3=; murine Has3, 5=-CCTTGGCGTTCA-GAAGATTTTC-3= and 5=-AGCTGCACCGGCATCCT-3=; murine CD44, 5=-TCCGAATTAGCTGGACACTC-3= and 5=-CCACAC-CTTCTCCTACTATTGAC-3=; murine RHAMM, 5=-ACAGCTGGAA-GAGGAAACGA-3= and 5=-TTTCCAACTGAGCAGTGACG-3=; canine HAS2, 5=-TGGGAGGAAGTGTGGATTATGTAC-3= and 5=-GGGTCAAGCATGGTGTCTGA-3=; canine HAS1, 5=-CCTGCATC-AGTGGTCCCC-3= and 5=-CTATGCCTAGGAAGGGCATCC-3=; canine HAS3, 5=-GCTCTTGGCGATTCAGTGGA-3= and 5=-CACAGT-GTCAGAGTCACAAACCTG-3=; and human HAS2, 5=-GTTATACAT-GTCGAGTTTACTTCC-3= and 5=-GTCATATTGTTGTCCCTTCTTC-CGC-3=.
Expression level of target genes was normalized using the following as endogenous control genes: mouse acidic ribosomal phosphoprotein P0, 5=-AATCTCCAGAGGCACCATTG-3= and 5=-GTTCAG-CATGTTCAGCTG-3=; mouse ActinB, 5=-CTAAGGCCAACCGT-GAAAAGAT-3=, and 5=-CACAGCCTGGATGGCTACGT-3=; mouse GusB, 5=-ACGGGATTGTGGTCATCGA-3= and 5=-TGACTCGTTGC-CAAAACTCTGA-3=; and canine RPS9, 5=-CGCCAGCGCCATAT-CAG-3= and 5=-GAAGGACGGGATGTTCACTACCT-3= (all primers were synthesized by Life Sciences).
Western blotting. For ERK and S6 kinetics, J3B1A and mCCD-N21 cells were grown on filter and treated apically and basally with TGF-␤1 (200 pg/ml) or HGF (7 ng/ml), respectively, and when mentioned, with 4-MU (0.5 mM). For all Western blot analyses, cells were homogenized in 100-l lysis buffer (20 mM Tris pH 7.4, 2 mM EGTA, 2 mM EDTA, 30 mM NaF, 30 mM Na 4P2O7, and 2 mM Na 3VO4) supplemented with 0.01% SDS, 1% Triton X-100, and an antiprotease cocktail (Complete Mini; Roche, Mannheim, Germany). Proteins were subjected to SDS-PAGE and blotted onto polyvinylidene difluoride membranes (Immobilion-P; Millipore, Bedford, MA). The proteins of interest were detected using polyclonal rabbit or monoclonal mouse antibodies anti-RHAMM (Santa Cruz Biotechnology, Santa Cruz, CA) and GAPDH (Millipopre). Phospho-ERK, phospho-S6, total ERK, and total S6 were from Cell Signaling. Horseradish peroxidase-conjugated secondary antibodies (BD Biosciences Pharmingen) were used for detection of immunoreactive proteins by chemiluminescence (horseradish peroxidase substrate; Immobilon Millipore).
RESULTS

Has2 is induced by tubulogenic factors in both mammary
and renal epithelial cells. We have previously shown that low concentrations of TGF-␤1 induce tubule formation in J3B1A mouse mammary epithelial cells grown in collagen gels (29) . To investigate the molecular mechanisms involved in the initiation of the tubulogenic process, we performed microarray analysis of J3B1A cells grown in collagen gels and treated or not treated with TGF-␤1 at low concentration (50 pg/ml) for 24 h. This analysis revealed that 282 genes were upregulated and 290 were downregulated at the time of initiation of tubulogenesis ( Fig. 1) . Data are available in the ArrayExpress database (see MATERIALS AND METHODS). Has2 mRNA expression was the most strongly induced transcript in response to TGF-␤1. We therefore assessed the role of Has2 and HA production in tubulogenesis.
Real-time PCR experiments confirmed the induction of Has2 mRNA expression, which was increased by 5-fold after 2 h and peaked with a 12-fold increase after 6 h of TGF-␤1 treatment of J3B1A cells grown in collagen gels ( Fig. 2A) . We Microarray analysis of J3B1A cells grown in collagen gels in the presence or absence of tubulogenic treatment. J3B1A cells were grown for 6 days in collagen gels until they formed cystic structures and then were treated or not treated with 50 pg/ml transforming growth factor-␤1 (TGF-␤1) to induce the formation of new branches. RNA of three independent experiments was extracted 24 h after treatment. Expression of 572 genes was modified by TGF-␤1 treatment; 282 were upregulated, and 290 were downregulated. Green, low expression level; red, high expression level. then extended our analysis to kidney-derived MDCK cells treated with the tubulogenic factor HGF (31). HAS2 mRNA expression was increased by 1.7-fold 2 h after HGF treatment (5 ng/ml), reached a plateau with a 2-fold increase between 6 h and 18 h, and returned to basal level at 24 h (Fig. 2B ). The induction of Has2 was specific because Has1 and Has3 were not expressed in J3B1A cells. In MDCK cells, HAS1 was not expressed and Has3 mRNA level was not modified after HGF treatment (Fig. 2B ). These results were therefore consistent with a role for Has2 in tubulogenesis.
We next confirmed that TGF-␤1-induced Has2 expression is associated with increased production of HA using a particle exclusion assay to visualize HA deposition around J3B1A cells (42) . Following incubation with a suspension of fixed erythrocytes, HA coats were detected as erythrocyte-devoid pericellular halos. TGF-␤1-treated J3B1A cells were surrounded by larger coats than control cells. Areas of erythrocyte exclusion were entirely absent following pretreatment with either 4-MU, a well-characterized inhibitor of HA synthesis (35) , or Streptomyces hyaluronidase (Fig. 2C) .
Inhibition of HA synthesis prevents tubulogenesis. As a preliminary step toward investigating the potential involvement of HA in tubulogenesis and branching, we confirmed that in the three culture models we used, tubule-lining cells dis- played a clear apico-basal polarity, as evidenced by basolateral localization of Na,K-ATPase in all three cell lines (Fig. 3A) and occurrence of primary cilia projecting from the apical membrane into the lumen of mCCD-N21 and MDCK cells (Fig. 3B) . Note that J3B1A cells do not display primary cilia.
To evaluate the role of HA in the tubulogenic process, we next treated J3B1A and MDCK cells with 4-MU. Addition of 1 mM 4-MU to preformed cysts of J3B1A cells completely prevented the extension of tubular processes in response to TGF-␤1 (Fig. 3C) . Remarkably, MDCK cells treated with HGF and 4-MU did not develop tubular structures but formed spherical cysts, similar to cells grown in the absence of HGF (31) (Fig. 3D) . These results suggested that HA production is necessary for initiation of the tubulogenic process.
To assess whether HA is necessary not only for the initial sprouting of epithelial tubules but also for their subsequent http://ajpcell.physiology.org/ elongation, we studied the effect of 4-MU on mCCD-N21 cells, a mouse renal collecting duct cell line that displays the ability to spontaneously form tubular structures in collagen/ Matrigel gels (30) . mCCD-N21 cells were treated with 0.25 mM 4-MU, a concentration that we previously found does not inhibit cell growth on plastic. Addition of 4-MU 2-4 days after seeding prevented both the elongation and branching of preformed tubular structures (Fig. 3E) . Collectively, the results obtained with three tubulogenic cell lines clearly show that HA production is necessary for both initial outgrowth formation and subsequent tubule elongation.
HA preferentially accumulates at the tips of growing tubules. We subsequently examined the distribution of HA in intact 3-D structures formed by J3B1A, MDCK, or mCCD-N21 cells using confocal microscopic analysis of whole mount gels (37, 40) . HA was abundantly and almost exclusively produced by cells sprouting from preformed cystic structures and at the tips of the elongating tubes (Fig. 4A) . Control experiments showed that HA staining was almost undetectable in cells treated with 4-MU (Fig. 4B) . Intra-or extracellular localization of HA was assessed by costaining with Na,KATPase. In J3B1A and mCCD-N21 cells, HA was almost exclusively detected inside the cells and at the cell membrane (Fig. 4C) . In MDCK cells, however, HA was also visualized in an extracellular location at the tips of elongating tubes (Fig.  4C) . Note that HA is notoriously difficult to preserve in the extracellular space and may have been washed away to a different extent during the fixation and immunostaining procedure. These data further support an important role for HA in promoting the collective migration that is required for tubule formation and elongation.
Has2 is necessary for tubular outgrowth in both mammary and renal epithelial cells. To corroborate the results obtained by pharmacological inhibition of HA production with 4-MU and to assess the specific role of Has2 in HA-mediated tubulogenesis, we silenced Has2 expression using RNA interference (RNAi). Specifically, J3B1A, MDCK, and mCCD-N21 cells were stably transduced with lentivi- ruses encoding shRNAs or miRNAs targeting the Has2 mRNA sequence.
After transduction with shRNA targeting Has2, a J3B1A sh1 clone treated with TGF-␤1 displayed a 70% decrease in Has2 mRNA induction compared with J3B1A cells expressing scramble shRNA (P Ͻ 0.05) (Fig. 5A) . The decrease in HA production in Has2-silenced sh1 cells was confirmed by a particle exclusion assay: in J3B1A cells expressing scramble shRNA, the HA-rich pericellular coat was thicker after TGF-␤1 treatment (Fig. 5B) , whereas in Has2-silenced sh1 cells the HA coat was undetectable even in response to TGF-␤1 (Fig. 5B) . These results indicated that Has2 is the major (if not exclusive) source of HA in J3B1A mammary epithelial cells. We then studied the effect of Has2 silencing on in vitro morphogenesis. J3B1A cells expressing scramble shRNA formed cysts or tubules when grown in collagen gel in the absence or presence of TGF-␤1, respectively (Fig. 5C) . Under control conditions, sh1 cells also formed cysts in collagen gels, showing that Has2 silencing did not impair cell growth and cystogenesis. Remarkably, however, induction of Results are expressed as means Ϯ SE from three independent experiments run in triplicate. *P Ͻ 0.05. B: HA production was visualized by the particle exclusion assay. TGF-␤1 treatment induces formation of HA-rich pericellular matrix in scramble (SCR) cells. No production of HA was visualized around sh1 cells, even after TGF-␤1 treatment. C: SCR and sh1 cells were grown in collagen gels for 6 days until they formed cysts and then were treated or not treated with TGF-␤1 at 50 pg/ml. Abrogation of Has2 expression prevented tube formation by sh1 cells. D: immunostaining of HA (red) shows heavy HA deposition in J3B1A-SCR cells extending out from the cystic structure and confirms the virtual lack of HA production in cysts formed by sh1 cells. Green, green fluorescent protein cytoplasmic staining. Scale bars ϭ 50 m. E: MDCK cells were transfected with plasmids expressing miRNA targeting the HAS2 gene (mi-1 cells) or control scramble miRNA (SCR). Levels of HAS2 mRNA were measured by real-time PCR in the presence of 7 ng/ml HGF. miRNA blunted HGF-mediated HAS2 induction. Results are expressed as means Ϯ SE from three independent experiments run in triplicate. *P Ͻ 0.05. F: MDCK SCR and miRNA expressing cells were grown in collagen gels in the absence or in presence of 5 ng/ml HGF. In absence of HGF, all cell lines form cystic structures. HGF induces tubule formation in SCR cells, whereas mi-1 cells do not form tubules and develop as cysts. Scale bars ϭ 50 m. G: immunostaining of HA shows conspicuous deposition of HA (red) at the extending tips of tubules formed by SCR cells. HA staining was not detectable around cysts formed by mi-1 cells. Green, GFP cytoplasmic staining. Scale bars ϭ 50 m. tubular outgrowths from the cyst wall by TGF-␤1 was strongly impaired in all Has2-silenced sh1 structures (Fig. 5C ). Immunostaining confirmed the absence of detectable HA around cysts formed by sh1 cells (Fig. 5D) . Therefore, Has2 silencing strongly corroborated the results obtained with inhibition of HA production by 4-MU.
The importance of HA synthesis by Has2 was also demonstrated in two distinct clones of MDCK cells transduced with miRNA. HAS2 was decreased by 80% in mi-1 compared with mi-scramble (mi-SCR) transduced cells (P Ͻ 0.05) (Fig. 5E ). In the absence of HGF treatment, SCR cells and HAS2-depleted clones developed cysts in collagen gels (Fig. 5F ). HGF treatment induced branched tubular outgrowths in SCR cells, whereas the Has2-depleted mi-1 clone was unable to develop branching structures in response to HGF and grew as hollow cysts (Fig. 5F ). The same results were observed in an mi-2 clone (data not shown). Immunohistochemistry revealed a strong HA staining at the tips of tubules generated by SCR cells, whereas HA was not detected around cysts formed by an HAS2-depleted clone (Fig. 5G) .
Using an additional model of Has2 downregulation, mCCD-N21 cells were transduced with doxycycline (Dox)-inducible lentiviral vectors encoding either SCR or miRNA targeting Has2 mRNA (miH2). Addition of Dox to the culture medium of miH2 cells decreased Has2 mRNA expression by 50% compared with cells grown in the absence of Dox (Fig. 6A) . mCCD-N21 SCR cells grown in 3-D cultures in the absence or presence of Dox developed branched tubular structures similar to those formed by mCCD-N21 miH2 cells grown in the absence of Dox. By contrast, in the presence of Dox, mCCD-N21 miH2 cells developed long and poorly ramified tubular structures (Fig. 6B) . These structures were similar in length to those formed in the absence of Dox (Fig. 6C ) but displayed less branching (P Ͻ 0.01; Fig. 6D ). Because exogenous addition of HA to the collagen matrix was reported to promote tubulogenesis (38), we wished to assess whether mCCD-N21 miH2 cells grown in the presence of Dox were able to develop branched tubules in collagen/Matrigel gels supplemented with HA. We found that addition of HA to the matrix increased branched tubulogenesis in both mCCD-N21 mi-SCR and miH2 cells, whether in the presence or absence of Dox (Fig. 6, E and F) .
Taken together, the findings reported above indicate that Has2 is the major enzyme responsible for HA synthesis in both the mammary and renal epithelial cell lines we used. More importantly, they demonstrate that endogenous HA produced by the epithelial cells themselves has the ability to promote branching without a requirement for preexistent HA in the surrounding matrix. 
Has2 is not sufficient by itself to drive the tubulogenic process.
To assess whether HA production is sufficient in itself (i.e., in the absence of a tubulogenic agent) to induce tubular outgrowths, we generated chimeric 3-D structures composed of two MDCK cell populations: a majority of cells expressing both HAS2 miRNA and GFP, among which a few cells overexpressing hHAS2 were interspersed (Fig. 7A) . To generate hHAS2 overexpressing cells, we stably transfected human hHAS2 cDNA under the control of tetracycline responsiveelement in MDCK Tet-Off cells. Real-time PCR experiments confirmed strong expression of hHAS2 in cells grown in the absence of Dox (Fig. 7B) . In MDCK Tet-Off cells stably transfected with the empty vector, hHAS2 mRNA was not detected. Despite the robust and selective production of HA by hHAS2-overexpressing MDCK cells (GFP-negative) in the absence of Dox, these aggregates developed exclusively as cystic structures (Fig. 7C) . These results confirm that although HA production is necessary, it is not by itself sufficient to drive the tubulogenic process.
The HA receptors CD44 and RHAMM are not necessary for the tubulogenic process. To gain insight into the molecular mechanisms underlying the effect of HA on tubulogenesis, we investigated the potential role of HA receptors in our model of tubulogenesis in vitro. We first examined the expression of CD44, the major HA receptor, in MDCK, mCCD-N21, and J3B1A cells grown in 3-D gels. In MDCK cells grown under control conditions, CD44 is expressed at the basolateral membrane of all cyst-lining cells. By contrast, in cells treated with HGF, CD44 was strongly expressed at the tips of elongating tubes, whereas it was almost undetectable along the tubular stalk (Fig. 8A) . However, this specific pattern of distribution was not observed in mCCD-N21 cells, where CD44 was expressed on the membrane of all tube-forming cells (day 4), with a clear basolateral staining at day 10 when the lumen is defined (Fig. 8B) . Finally, in J3B1A cells, CD44 staining was observed inconsistently along the tubular stalk and was often excluded from the tips of growing tubes (Fig. 8C) . Therefore, contrasting with the polarized expression of HA at the tips of growing tubes in all cell lines studied, the expression pattern of CD44 is cell-line specific and does not colocalize with sites of HA accumulation.
To evaluate the relevance of HA-CD44 interaction in the tubulogenic process, we transduced J3B1A and mCCD-N21 cells with miRNA targeting the common part of CD44 mRNA variants in a Dox-inducible manner (8) . CD44 expression was greatly reduced in both cell lines (ϳ80%) as demonstrated by real-time PCR analysis (Fig. 9, A and B) . When CD44-silenced J3B1A and mCCD-N21 cells were grown in 3-D cultures in the presence of Dox, they both developed branched tubular structures (Fig. 9, C and D) , although they did not express CD44 on the basolateral membrane of structure lining cells, as confirmed by CD44 immunostaining (Fig. 9, E and F) .
RHAMM is an additional HA receptor involved in cell migration, adhesion, and proliferation. We transduced J3B1A and mCCD-N21 cells with miRNA targeting RHAMM mRNA in a Dox-inducible manner. As shown by real-time PCR, Dox treatment decreased RHAMM mRNA levels by 60% and 80% in J3B1A and mCCD-N21 cells, respectively (Fig. 10, A and  B) . Western blot experiments confirmed efficient RHAMM silencing at the protein level in both cell lines (Fig. 10, C and  D) . However, the tubulogenic ability of J3B1A and mCCD-N21 RHAMM-silenced cells grown in 3-D cultures were not affected (Fig. 10, E and F) .
Taken together, these data indicate that the tubulogenesisinducing activity of HA is neither CD44-nor RHAMMmediated.
Cell proliferation is involved in the growth of new branches. To evaluate the contribution of cell proliferation to the development of new branches, we examined the expression of the proliferation marker Ki67 in structures formed in the absence or presence of tubulogenic agents. Treatment of J3B1A cells with TGF-␤1 did not increase the number of proliferating cells in cystic structures. However, a strong Ki67 staining was observed in nuclei of cells at the basis of new tubular branches (Fig. 11) . Treatment of MDCK cells with HGF induced cell proliferation, compared with untreated cells (Fig. 11) .
HA synthesis allows sustained signaling by growth factors. In an attempt to further elucidate the mechanisms of HAinduced tubulogenesis, we asked whether endogenously produced HA could modify cytokine-activated intracellular sig- naling. To address this issue, we focused on the MEK-ERK pathway, which is required for tubulogenesis in cultures of HGF-treated MDCK cells (37) and TGF-␤1-treated J3B1A cells (29) . J3B1A and mCCD-N21 cells were grown on filters in the presence or absence of the HA synthesis inhibitor 4-MU (0.5 mM) during 48 h, and the phosphorylation levels of ERK and those of S6 kinase (an enzyme required for cell growth) were assessed at different times after cytokine treatment.
TGF-␤1 or HGF treatments induced a biphasic increase of ERK phosphorylation in both J3B1A and mCCD-N21 cells. After an initial rapid increase, ERK phosphorylation decreased transiently to undergo a second increase after 40 h of cytokine treatment (Fig. 12, A and B) . Although the time course of phosphorylation exhibited some variations between individual experiments, the characteristic biphasic activation of ERK was highly reproducible. In contrast, in cells grown in the presence of 4-MU, we observed a clear change in the kinetics of ERK phosphorylation, which was uniformly increased from 0.5 to 24 h. Notably, the biphasic effect was suppressed and the sustained activation of ERK observed at 40 h was no longer apparent (Fig. 12, A and B) .
The kinetics of S6 phosphorylation were also modified by 4-MU treatment. In J3B1A and mCCD-N21 cells, cytokine treatment induced S6 phosphorylation from 0.5 to 48 h. This induction was not sustained after 24 h in the presence of 4-MU (Fig. 12, C and D) .
These results suggest that HA synthesis is necessary to generate a prolonged response to TGF-␤1 or HGF treatment in J3B1A and mCCD-N21 cells, respectively.
DISCUSSION
Formation of branched tubes from an initially unbranched epithelial bud is a fundamental process in the development of many organs, including kidney, mammary gland, lung, and pancreas. Studies conducted over the last 2 decades have allowed identification of a number of growth factors and cytokines that are able to stimulate tubule outgrowth and branching in in vitro assays of epithelial tubulogenesis (26, 45) . However, their effector mechanisms are still incompletely understood (39, 57) . Remodeling of the ECM at the interface between incipient tubular outgrowths and the surrounding collagenous stroma is believed to be a prerequisite for tubule elongation and branching. Thus controlled degradation of the pericellular matrix by membrane-associated metalloproteinases (MMPs) (22, 25) , as well as spatially restricted deposition of selected ECM components at specific locations of growing epithelial buds (44) , have been shown to play a critical role in the process of branching morphogenesis.
HA is a high molecular weight glycosaminoglycan that, owing to its peculiar physicochemical properties, has the ability to confer turgescence and malleability to the ECM, thereby creating a microenvironment that is conductive to cell migration (23, 41, 51) . In addition, HA is known to directly stimulate cell motility by binding and activating specific cell surface receptors, among which the most extensively characterized are CD44 (53) and RHAMM (36) . Previous work has suggested a role for HA in branching morphogenesis. Thus during mouse kidney development, the maximal amounts of HA are found concomitantly with the onset of the tubular branching process at day 11, and thereafter, HA abundance decreases until birth (5) . In in vitro morphogenesis assays, addition of HA to the collagen matrix was reported to enhance tubule formation and branching by renal or mammary gland cells or organ cultures (11, 38, 48) These studies indicated that enrichment of the ECM with exogenously added HA (arguably mimicking in vivo HA deposition by stromal fibroblasts) can promote epithelial tubulogenesis. We considered it likely, however, that localized secretion of HA by the epithelial cells themselves might be more relevant to the process of branching tubulogenesis. In the present study, we therefore adopted the strategy of modulating the expression and/or functional activity of HAsynthesizing enzymes in mammary gland and kidney epithelial cells to assess the potential impact of endogenously produced HA on tubule formation and branching.
For this purpose, we employed three distinct in vitro models of epithelial morphogenesis in which tubule formation occurs either spontaneously [collecting duct mCCD-N21 cells (30) TGF-␤1 [mammary gland J3B1A cells (29) ]. It is worth noting that in the latter model, tubulogenesis is induced by concentrations of TGF-␤1 (50 pg/ml) much lower than those previously reported to inhibit tubule elongation or branching (9, 46, 47) . Interestingly, a recent study has provided evidence that TGF-␤1 also exerts a biphasic effect on MDCK cells: it enhances tubulogenesis at low concentrations (10 -100 pg/ml) but inhibits it at high concentrations (1-10 ng/ml) (55) .
We found that both HGF and TGF-␤1 (which we use to induce tubulogenesis in MDCK and J3B1A cells, respectively) strongly upregulated the HA-synthesizing enzyme Has2 while leaving Has1 and Has3 isoforms expression virtually unaffected. The selective induction of Has2 by tubulogenic factors is in agreement with the notion that each Has exhibits different catalytic properties and expression patterns during embryonic development, suggesting that they play distinct biological roles (49) , and that the Has2 isoform is the most extensively regulated Has isoform in response to external stimuli (24) . Notably, mouse embryos deficient in Has2 die in utero due to a failure in cardiac tube formation, whereas those lacking Has1 or Has3 show no major defect (10) . The finding that Has2 was induced a few hours after addition of either TGF-␤1 or HGF suggests that this enzyme is involved in the initiation of the tubulogenic process. In this respect, it is relevant that collecting duct mCCD-N21 cells, which spontaneously form branched tubules in a 3-D matrix environment (30) , constitutively express Has2 (data not shown).
To assess the potential requirement for Has2-mediated HA production in epithelial tubulogenesis, we suppressed HA synthesis either through the use of the pharmacological inhibitor 4-MU or by silencing Has2 expression. From both series of experiments, it emerged that inhibition of HA production by epithelial cells does not perturb cyst formation (thus cell proliferation) by either MDCK or J3B1A cells, yet it severely disrupts the formation of tubular outgrowths normally observed in response to HGF or TGF-␤1, respectively. Notably, addition of 4-MU also prevented further extension of preformed tubules in cultures of MDCK, J3B1A, and mCCD-N21 cells. Collectively, these finding indicate that HA production is necessary for both initiation of the tubulogenic process and the subsequent elongation and branching of incipient tubular structures. It is important to underscore that suppression of HA production consistently abrogated tubule formation in three different 3-D assays, irrespective of the tissue origin of cells (kidney or mammary gland) and of the inducing stimulus applied (HGF or TGF-␤1), suggesting a similar role for HA in the development of many parenchymal organs.
An important finding in our study is that HA is selectively localized near the tips of tubular outgrowths. This finding suggests that focal accumulation of HA at the leading edge of growing tubules creates a specialized ECM microenvironment that fosters collective cell migration and morphogenetic cell rearrangements, thereby promoting the elongation and ramification of existing tubules. HA may promote cell migration (23, 41) by distinct, mutually nonexclusive mechanisms. First, HA generates a highly hydrated and malleable ECM that may facilitate cell translocation (52) . Second, HA binds to specific cell surface receptors (e.g., CD44 and RHAMM), which transduce intracellular signals that ultimately modulate epithelial cell proliferation and differentiation (7) . Several pieces of experimental evidence have previously suggested that the HA-CD44 axis plays a key role in renal epithelial cell tubulogenesis (19, 38) . In the present study, we show that HGF specifically induces CD44 expression at the tips of the growing tubes formed by MDCK cells, a localization that closely matches the selective accumulation of HA in the same regions. This finding is in agreement with the reported specific expression of CD44 at the leading edge of growing ureteric buds (38) . However, the localization of CD44 in mCCD-N21 and J3B1A cells did not specifically match the selective accumulation of HA at the tips of the growing tubes. In addition, specific silencing of CD44 had no effect on tubulogenesis, suggesting that CD44 is not involved in this morphogenetic process, at least under our experimental conditions. The discrepancy between our results ant those previously reported by (38) could be due to the fact that we blunted CD44 expression by silencing RNA instead of using CD44 blocking antibody. In addition, by silencing RHAMM in J3B1A and mCCD-N21 cells, we found that this receptor is also dispensable for HA-induced tubulogenesis. Although our data indicate that HA does not promote tubulogenesis through either CD44 or RHAMM, the potential role of additional receptors such as LAYN (7) cannot be excluded at present.
It has been reported that formation of tubular outgrowths from cysts generated by MDCK cells involves not only increased cell proliferation, but also a change in the cell division axis that allows the first cell to leave the original structure (56) . Interestingly, Fujiwara et al. showed that addition of HA to the basolateral pole of epithelial cells induces a rotation of the mitotic spindle, which becomes oblique with respect to the basal lamina (18) . In light of these findings, it is tempting to speculate that localized HA production modifies mitotic spindle orientation in a subset of epithelial cells, thereby fostering initiation of tubulogenesis. We found, however, that local production of HA in selected cells of MDCK cysts do not induce tubular outgrowth at their specific location, suggesting that HA production is not sufficient by itself to drive the tubulogenic process and that the impact of soluble tubulogenic factors might be necessary as well.
A further mechanism by which HA may promote cell migration and/or proliferation is through its interaction with growth factors. Indeed, the glycosaminoglycan moiety of proteoglycans is known to bind and concentrate growth factors in the vicinity of cell membranes, thereby increasing their ability to interact with specific cell surface receptors (12, 50) . Thus HGF binding to heparan sulfate is required for its proper function (13) . In our study, addition of HGF or TGF-␤1 at the basolateral pole of mCCD-N21 and J3B1A cells, respectively, resulted in a sustained induction of ERK and S6 phosphorylation. The quick induction of ERK and S6 phosphorylation was not 4-MU sensitive. By contrast, blocking HA production by 4-MU inhibits the sustained response to cytokine treatment (24 to 48 h). HGF or TGF-␤1 treatment activate downstream signaling pathways that induce Has2 expression and pericellular HA deposition, which in turn could help maintaining a sustained response to these cytokines. We have previously shown that the ERK pathway is involved in branching of J3B1A cells (29) . Moreover, sustained activation of ERK phosphorylation is required for mammary epithelial branching morphogenesis (16) , whereas lower levels of ERK phosphorylation are associated with a decrease in kidney branching tubulogenesis (17) . Accordingly, we hypothesize that the high abundance of HA at the leading edge of growing tubules increases the local availability of tubulogenic cytokines, thereby enhancing their biological activity. However, the precise mechanism by which HA induces ERK and S6 sustained signaling and promotes tubulogenesis will need further exploration.
In conclusion, we provide in vitro evidence that spatially restricted deposition of HA by epithelial cells plays a pivotal role in epithelial tubulogenesis by promoting tubular branching in a cell-autonomous manner (i.e., without a requirement for HA production by mesenchymal cells). Although HA is a common factor required for induction of branching tubulogen- D) were grown in the absence or presence of 4-MU for 48 h and treated for various times with 100 pg/ml TGF-␤1 or 10 ng/ml HGF. A and B: ERK phosphorylation and ERK total analysis. C and D: S6 phosphorylation and S6 total analysis. esis in our three different models, intracellular mechanisms leading to the establishment of a new branch (i.e., remodeling of cell-cell adhesion, cell proliferation, migration, ѧ) might differ downstream of HA (57) .
